US Patent Issued to Arrowhead pharmaceuticals on March 24 for "Integrin targeting ligands and uses thereof" (Wisconsin, New Jersey Inventors)

ALEXANDRIA, Va., March 24 -- United States Patent no. 12,582,718, issued on March 24, was assigned to Arrowhead pharmaceuticals Inc. (Pasadena, Calif.).

"Integrin targeting ligands and uses thereof" was invented by Zhen Li (Westfield, N.J.), Jeffrey Carlson (Madison, Wis.), Anthony Nicholas (Oregon, Wis.), Xiaokai Li (Middleton, Wis.), Dongxu Shu (Madison, Wis.) and Matthew Fowler-Watters (Madison, Wis.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Compounds having affinity for integrins, the synthesis of these compounds, and the use of these compounds as ligands to facilitate the delivery of cargo molecules to cells expressing integrins are described. The described integrin targeting ligands have serum sta...